Evidence map›Paper›PMID 27439414›Full record

ArticleArchives of toxicology2016

One-year oral toxicity study on a genetically modified maize MON810 variety in Wistar Han RCC rats (EU 7th Framework Programme project GRACE).

Dagmar Zeljenková, Radka Aláčová, Júlia Ondrejková, Katarína Ambrušová, Mária Bartušová, Anton Kebis, Jevgenij Kovrižnych, Eva Rollerová, Elena Szabová, Soňa Wimmerová and 28 more

Open access · hybridAbstract read
In one paragraph

Article in Archives of toxicology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
13.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Advancing human health risk assessment.EFSA journal. European Food Safety Authority · 2019
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors at 11 institutions in 6 countries.

Dagmar ZeljenkováFaculty of Public Health, Slovak Medical University in Bratislava, Limbová 12, 83303, Bratislava, Slovakia.
Radka AláčováFaculty of Public Health, Slovak Medical University in Bratislava, Limbová 12, 83303, Bratislava, Slovakia.
Júlia OndrejkováFaculty of Public Health, Slovak Medical University in Bratislava, Limbová 12, 83303, Bratislava, Slovakia.
Katarína AmbrušováFaculty of Public Health, Slovak Medical University in Bratislava, Limbová 12, 83303, Bratislava, Slovakia.
Mária BartušováFaculty of Public Health, Slovak Medical University in Bratislava, Limbová 12, 83303, Bratislava, Slovakia.
Anton KebisFaculty of Public Health, Slovak Medical University in Bratislava, Limbová 12, 83303, Bratislava, Slovakia.
Jevgenij KovrižnychFaculty of Public Health, Slovak Medical University in Bratislava, Limbová 12, 83303, Bratislava, Slovakia.
Eva RollerováFaculty of Public Health, Slovak Medical University in Bratislava, Limbová 12, 83303, Bratislava, Slovakia.
Elena SzabováFaculty of Public Health, Slovak Medical University in Bratislava, Limbová 12, 83303, Bratislava, Slovakia.
Soňa WimmerováFaculty of Public Health, Slovak Medical University in Bratislava, Limbová 12, 83303, Bratislava, Slovakia.
Martin ČernákFaculty of Medicine, Slovak Medical University in Bratislava, Limbová 12, 83303, Bratislava, Slovakia.
Zora KrivošíkováFaculty of Medicine, Slovak Medical University in Bratislava, Limbová 12, 83303, Bratislava, Slovakia.
Miroslava KuricováFaculty of Medicine, Slovak Medical University in Bratislava, Limbová 12, 83303, Bratislava, Slovakia.
Aurélia LíškováFaculty of Medicine, Slovak Medical University in Bratislava, Limbová 12, 83303, Bratislava, Slovakia.
Viera SpustováFaculty of Medicine, Slovak Medical University in Bratislava, Limbová 12, 83303, Bratislava, Slovakia.
Jana TulinskáFaculty of Medicine, Slovak Medical University in Bratislava, Limbová 12, 83303, Bratislava, Slovakia.
Mikuláš LevkutUniversity of Veterinary Medicine and Pharmacy in Košice and TOPALAB, Kamenicna 7, 01015, Košice, Slovakia.
Viera RévajováUniversity of Veterinary Medicine and Pharmacy in Košice and TOPALAB, Kamenicna 7, 01015, Košice, Slovakia.
Zuzana ŠevčíkováUniversity of Veterinary Medicine and Pharmacy in Košice and TOPALAB, Kamenicna 7, 01015, Košice, Slovakia.
Kerstin SchmidtBioMath GmbH, Schnickmannstr. 4, 18055, Rostock, Germany.
Jörg SchmidtkeBioMath GmbH, Schnickmannstr. 4, 18055, Rostock, Germany.
Paul SchmidtBioMath GmbH, Schnickmannstr. 4, 18055, Rostock, Germany.
Jose Luis La PazCentre for Research in Agricultural Genomics (CRAG), Edifici CRAG, Campus UAB, 08193, Cerdanyola, Barcelona, Spain.
Maria CorujoCentre for Research in Agricultural Genomics (CRAG), Edifici CRAG, Campus UAB, 08193, Cerdanyola, Barcelona, Spain.
Maria PlaUniversitat de Girona (UDG), Edifici EPS1, Campus Montilivi, 17071, Girona, Spain.
Gijs A KleterRIKILT Wageningen UR, Wageningen University and Research Centre, Akkermaalsbos 2, 6708WB, Wageningen, The Netherlands.
Esther J KokRIKILT Wageningen UR, Wageningen University and Research Centre, Akkermaalsbos 2, 6708WB, Wageningen, The Netherlands.
Jutta SharbatiInstitute of Veterinary Biochemistry, Freie Universität Berlin, Oertzenweg 19b, 14163, Berlin, Germany.
Marc BohmerInstitute of Veterinary Biochemistry, Freie Universität Berlin, Oertzenweg 19b, 14163, Berlin, Germany.
Nils BohmerInstitute of Veterinary Biochemistry, Freie Universität Berlin, Oertzenweg 19b, 14163, Berlin, Germany.
Ralf EinspanierInstitute of Veterinary Biochemistry, Freie Universität Berlin, Oertzenweg 19b, 14163, Berlin, Germany.
Karine Adel-PatientINRA, UR496 Immuno-Allergie Alimentaire, CEA/IBiTeC-S/SPI, CEA de Saclay, 91191, Gif Sur Yvette Cedex, France.
Armin SpökIFZ-Inter-University Research Centre for Technology, Work and Culture (IFZ), Schlögelgasse 2, 8010, Graz, Austria.
Annette PötingFederal Institute for Risk Assessment, Max-Dohrn-Straße 8-10, 10589, Berlin, Germany.
Christian KohlInstitute for Biosafety in Plant Biotechnology, Julius Kühn-Institut, Federal Research Centre for Cultivated Plants, Erwin-Baur-Str. 27, 06484, Quedlinburg, Germany.
Ralf WilhelmInstitute for Biosafety in Plant Biotechnology, Julius Kühn-Institut, Federal Research Centre for Cultivated Plants, Erwin-Baur-Str. 27, 06484, Quedlinburg, Germany.
Joachim SchiemannInstitute for Biosafety in Plant Biotechnology, Julius Kühn-Institut, Federal Research Centre for Cultivated Plants, Erwin-Baur-Str. 27, 06484, Quedlinburg, Germany.
Pablo SteinbergInstitute for Food Toxicology and Analytical Chemistry, University of Veterinary Medicine Hannover, Bischofsholer Damm 15, 30173, Hannover, Germany. pablo.steinberg@tiho-hannover.de.
Slovak Medical University · SKFreie Universität Berlin · DEJulius Kühn-Institut · DEUniversity of Veterinary Medicine in Košice · SKCenter for Research in Agricultural Genomics · ESWageningen University & Research · NLFederal Institute for Risk Assessment · DEInstitut de Biologie et Technologies · FRInterdisciplinary Research Centre for Technology, Work and Culture · ATUniversity of Girona · ESUniversity of Veterinary Medicine Hannover, Foundation · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The GRACE (GMO Risk Assessment and Communication of Evidence; www.grace-fp7.eu ) project was funded by the European Commission within the 7th Framework Programme. A key objective of GRACE was to conduct 90-day animal feeding trials, animal studies with an extended time frame as well as analytical, in vitro and in silico studies on genetically modified (GM) maize in order to comparatively evaluate their use in GM plant risk assessment. In the present study, the results of a 1-year feeding trial with a GM maize MON810 variety, its near-isogenic non-GM comparator and an additional conventional maize variety are presented. The feeding trials were performed by taking into account the guidance for such studies published by the EFSA Scientific Committee in 2011 and the OECD Test Guideline 452. The results obtained show that the MON810 maize at a level of up to 33 % in the diet did not induce adverse effects in male and female Wistar Han RCC rats after a chronic exposure.

Indexed as

Animal FeedHealth StatusAnimalsFemaleFood, Genetically ModifiedMalePlants, Genetically ModifiedRats, Inbred StrainsRisk AssessmentToxicity Tests, ChronicZea maysChronic oral toxicity studyFood/Feed Guidance Document of the EFSA Scientific Committee (2011)Genetically modified maize MON810GRACEOECD Test Guideline No. 452–Chronic toxicity studies (2009)Rat feeding trial

Identifiers

PMID27439414
PMCPMC5043003
OpenAlexW2504930139

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.